MedTrace Logo

Multiple Dose Healthy Volunteer Study of PF-03715455.

NCT01186757 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2011-01-12

No results posted yet for this study

Summary

Evaluation of the multiple dose pharmacokinetics of PF-3715455 in healthy volunteers

Conditions

  • Healthy Volunteers

Interventions

DRUG

PF-03715455

PF-03715455 1.6 mg BID

DRUG

PF-03715455

PF-03715455 4mg BID

DRUG

PF-03715455

PF-03715455 10 mg BID

DRUG

Placebo

Placebo

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01186757 on ClinicalTrials.gov